NATALIE KERBER: Open Payments
NPI 1184075160 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 151 payments from 25 companies in 2025. Trend: 2023 $1,950 · 2024 $2,848 · 2025 $2,944
Food & beverage: $2,944
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $349 |
| PFIZER INC. | 16 | $302 |
| Phathom Pharmaceuticals, Inc. | 34 | $302 |
| ABBVIE INC. | 14 | $297 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $270 |
| Lilly USA, LLC | 10 | $234 |
| Astellas Pharma US Inc | 6 | $136 |
| Hologic Sales and Service, LLC | 1 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $113 |
| Axsome Therapeutics, Inc. | 4 | $99 |
Products named: AIRSUPRA, VOQUEZNA, Kerendia, NURTEC ODT, Veozah, VRAYLAR, APTIMA, CAPLYTA.
Industry payments across WI — which companies pay providers there.
